The page is the record's research on the issuer — no analyst, no rating, no view. # Neumora Therapeutics, Inc. (NASDAQ: NMRA) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Neumora Therapeutics, Inc., listed on NASDAQ under ticker NMRA, with ISIN US6409791000. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). Its security type is Corporate, its segment is not on the record, its sector is 2836 Biological Products, (No Diagnostic Substances), and its jurisdiction is United States, Delaware. Its listing status is listed, not halted. ## The disclosure read The record holds 53 filings in the window 2025-11-08 to 2026-11-08, across 25 filing days. The median gap between filing days is 7.0 days. The latest filing is dated 2026-10-30, a halt_suspension filing, 9 days before the record date of 2026-11-08. The exchange median gap is 6.0 days across 4359 issuers, and the exchange median latency is 5.0 days. The sector median gap is 5.5 days across 176 issuers, and the sector median latency is 4.0 days. The issuer's filing count is 53, against an exchange median of 52 and a sector median of 65.5. ## Auditor The auditor of record is Ernst & Young LLP, located in San Jose, California. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change events. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations page. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds the issuer's years 2021, 2022, 2023, 2024, 2025 and 2026 as sealed. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001885522.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/NMRA (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1885522/000119312526130388/nmra-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/NMRA (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/NMRA · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp